Medifoxamine

CAS No. 32359-34-5

Medifoxamine( —— )

Catalog No. M34001 CAS No. 32359-34-5

Medifoxamine (LG 152) is a selective non-monoamine oxidase inhibitor that exhibits antidepressant activity through inhibition of 5 HT reuptake.Medifoxamine preferentially inhibits dopamine reuptake.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 258 In Stock
5MG 235 In Stock
10MG 353 In Stock
25MG 635 In Stock
50MG 873 In Stock
100MG 1135 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Medifoxamine
  • Note
    Research use only, not for human use.
  • Brief Description
    Medifoxamine (LG 152) is a selective non-monoamine oxidase inhibitor that exhibits antidepressant activity through inhibition of 5 HT reuptake.Medifoxamine preferentially inhibits dopamine reuptake.
  • Description
    Medifoxamine is a monoamine re-uptake inhibiting antidepressive agent which preferentially inhibits dopamine reuptake.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine Receptor | Monoamine Oxidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    32359-34-5
  • Formula Weight
    257.33
  • Molecular Formula
    C16H19NO2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (388.61 mM; Ultrasonic )
  • SMILES
    CN(C)CC(Oc1ccccc1)Oc1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Saleh S, et al. Ocular hypotensive effects of medifoxamine. Br J Clin Pharmacol. 1992;34(3):269-271.?
molnova catalog
related products
  • Nomifensine (maleate...

    Nomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.

  • PF-00217830

    PF-00217830 is a serotonin 1A receptor agonist, dopamine D2 receptor agonist, and serotonin 2A receptor antagonist.PF-00217830 may be used in the study of schizophrenia.

  • Spiperone

    A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.